受强制性开放获取政策约束的文章 - Daniel Gusenleitner了解详情
可在其他位置公开访问的文章：21 篇
Targetable genetic features of primary testicular and primary central nervous system lymphomas
B Chapuy, MGM Roemer, C Stewart, Y Tan, RP Abo, L Zhang, AJ Dunford, ...
Blood, The Journal of the American Society of Hematology 127 (7), 869-881, 2016
强制性开放获取政策： US National Institutes of Health
MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma
SJ Rodig, D Gusenleitner, DG Jackson, E Gjini, A Giobbie-Hurder, C Jin, ...
Science translational medicine 10 (450), eaar3342, 2018
强制性开放获取政策： US National Institutes of Health
Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma
CD Carey, D Gusenleitner, M Lipschitz, MGM Roemer, EC Stack, E Gjini, ...
Blood, The Journal of the American Society of Hematology 130 (22), 2420-2430, 2017
强制性开放获取政策： US National Institutes of Health, Blood Cancer UK, UK Engineering and …
Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients
PB Subrahmanyam, Z Dong, D Gusenleitner, A Giobbie-Hurder, ...
Journal for immunotherapy of cancer 6, 1-14, 2018
强制性开放获取政策： US National Institutes of Health
An aryl hydrocarbon receptor-mediated amplification loop that enforces cell migration in ER−/PR−/Her2− human breast cancer cells
O Novikov, Z Wang, EA Stanford, AJ Parks, A Ramirez-Cardenas, ...
Molecular pharmacology 90 (5), 674-688, 2016
强制性开放获取政策： US National Science Foundation, US National Institutes of Health
Cancer-germline antigen expression discriminates clinical outcome to CTLA-4 blockade
SA Shukla, P Bachireddy, B Schilling, C Galonska, Q Zhan, C Bango, ...
Cell 173 (3), 624-633. e8, 2018
强制性开放获取政策： US Department of Defense, US National Institutes of Health, Howard Hughes …
GeneSigDB: a manually curated database and resource for analysis of gene expression signatures
AC Culhane, MS Schröder, R Sultana, SC Picard, EN Martinelli, C Kelly, ...
Nucleic acids research 40 (D1), D1060-D1066, 2012
强制性开放获取政策： US National Institutes of Health
Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525)±anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies
P Schöffski, DSW Tan, M Martín, M Ochoa-de-Olza, J Sarantopoulos, ...
Journal for immunotherapy of cancer 10 (2), 2022
强制性开放获取政策： US National Institutes of Health
Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease
B Chapuy, H Cheng, A Watahiki, MD Ducar, Y Tan, L Chen, MGM Roemer, ...
Blood, The Journal of the American Society of Hematology 127 (18), 2203-2213, 2016
强制性开放获取政策： US National Institutes of Health
Genomic models of short-term exposure accurately predict long-term chemical carcinogenicity and identify putative mechanisms of action
D Gusenleitner, SS Auerbach, T Melia, HF Gomez, DH Sherr, S Monti
PloS one 9 (7), e102579, 2014
强制性开放获取政策： US National Institutes of Health
iBBiG: iterative binary bi-clustering of gene sets
D Gusenleitner, EA Howe, S Bentink, J Quackenbush, AC Culhane
Bioinformatics 28 (19), 2484-2492, 2012
强制性开放获取政策： US National Institutes of Health
Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma
GK Griffin, JL Weirather, MGM Roemer, M Lipschitz, A Kelley, PH Chen, ...
Blood, The Journal of the American Society of Hematology 137 (10), 1353-1364, 2021
强制性开放获取政策： US National Institutes of Health
ASSIGN: context-specific genomic profiling of multiple heterogeneous biological pathways
Y Shen, M Rahman, SR Piccolo, D Gusenleitner, NN El-Chaar, L Cheng, ...
Bioinformatics 31 (11), 1745-1753, 2015
强制性开放获取政策： US National Institutes of Health
RamiGO: an R/Bioconductor package providing an AmiGO visualize interface
MS Schröder, D Gusenleitner, J Quackenbush, AC Culhane, ...
Bioinformatics 29 (5), 666-668, 2013
强制性开放获取政策： US National Institutes of Health
Molecular classification of MYC-driven B-cell lymphomas by targeted gene expression profiling of fixed biopsy specimens
CD Carey, D Gusenleitner, B Chapuy, AE Kovach, MJ Kluk, HH Sun, ...
The Journal of Molecular Diagnostics 17 (1), 19-30, 2015
强制性开放获取政策： US National Institutes of Health
Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma
R Váraljai, L Zimmer, Y Al-Matary, P Kaptein, LJ Albrecht, B Shannan, ...
Nature cancer 4 (9), 1292-1308, 2023
强制性开放获取政策： German Research Foundation
GCOD-GeneChip Oncology Database
F Liu, J White, C Antonescu, J Quackenbush
BMC bioinformatics 12 (1), 46, 2011
强制性开放获取政策： US National Institutes of Health
Role of tumor-infiltrating B cells in clinical outcome of patients with melanoma treated with dabrafenib plus trametinib
JC Brase, RFH Walter, A Savchenko, D Gusenleitner, J Garrett, ...
Clinical Cancer Research 27 (16), 4500-4510, 2021
强制性开放获取政策： German Research Foundation
Targetable subsets of non-Hodgkin lymphoma in Malawi define therapeutic opportunities
EA Morgan, MP Sweeney, T Tomoka, N Kopp, D Gusenleitner, RA Redd, ...
Blood advances 1 (1), 84-92, 2016
强制性开放获取政策： US National Institutes of Health
Improving specificity for ovarian cancer screening using a novel extracellular vesicle–based blood test: performance in a training and verification cohort
ES Winn-Deen, LT Bortolin, D Gusenleitner, KM Biette, K Copeland, ...
The Journal of Molecular Diagnostics 26 (12), 1129-1148, 2024
强制性开放获取政策： UK Medical Research Council
出版信息和资助信息由计算机程序自动确定